Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
34,519,697
-
Share change
-
-643,147
-
Total reported value
-
$5,890,695,868
-
Put/Call ratio
-
175%
-
Price per share
-
$170.56
-
Number of holders
-
274
-
Value change
-
-$225,320,254
-
Number of buys
-
151
-
Number of sells
-
179
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q1 2022
As of 31 Mar 2022,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
274 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,519,697 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, Pendal Group Ltd, FLOSSBACH VON STORCH AG, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Fosun International Ltd, Capital World Investors, and D. E. Shaw & Co., Inc..
This page lists
274
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.